Endoscopic Sclerotherapy for Esophageal Variceal Hemorrhage

Robert S. Gordon, Bennett M. Derby, John P. Cello, James H. Grendell, Richard A. Crass, Donald D. Trunkey, Thorkild I.a. Sørensen, Peter Matzen, Flemming Burcharth, Bjørn Andersen

    Research output: Contribution to journalLetter

    2 Scopus citations

    Abstract

    To the Editor: How could the Journal, which six years earlier published a landmark paper on the need for adequate sample size in controlled clinical trials,1 now publish without comment the paper by Cello et al. (Dec. 20 issue),2 which overinterprets the negative results of a trial based on a very modest number of patients? These authors randomly assigned 52 patients to one of two alternative forms of treatment and “failed to demonstrate any significant difference in long-term survival. …” They go on to state that “acute and vigorously repeated endoscopic sclerotherapy is at least as good as, and.

    Original languageEnglish (US)
    Pages (from-to)989-990
    Number of pages2
    JournalNew England Journal of Medicine
    Volume312
    Issue number15
    DOIs
    StatePublished - Apr 11 1985

    ASJC Scopus subject areas

    • Medicine(all)

    Fingerprint Dive into the research topics of 'Endoscopic Sclerotherapy for Esophageal Variceal Hemorrhage'. Together they form a unique fingerprint.

  • Cite this

    Gordon, R. S., Derby, B. M., Cello, J. P., Grendell, J. H., Crass, R. A., Trunkey, D. D., Sørensen, T. I. A., Matzen, P., Burcharth, F., & Andersen, B. (1985). Endoscopic Sclerotherapy for Esophageal Variceal Hemorrhage. New England Journal of Medicine, 312(15), 989-990. https://doi.org/10.1056/NEJM198504113121513